Listed

Champions Oncology, Inc.

CSBRNasdaqCIK 771856HealthcareFiscal year ends Apr 30

Reports and events: 248 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Champions Oncology, Inc., Reports and events
FiledFormWhat it isAccession number
2022-08-2915:18 ETDEF 14AProxy statementPeriod 2022-08-290001628280-22-023824
2022-07-2216:28 ET10-KAnnual reportPeriod 2022-04-300001628280-22-019309
2022-07-2115:59 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001628280-22-019249
2022-03-1517:18 ET10-QQuarterly reportPeriod 2022-01-310001628280-22-006298
2022-03-1516:31 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001628280-22-006255
2021-12-1317:00 ET10-QQuarterly reportPeriod 2021-10-310001628280-21-024951
2021-12-1315:59 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001628280-21-024928
2021-10-2112:51 ET8-K5.07 Shareholder vote results0001628280-21-020321
2021-09-1317:00 ET10-QQuarterly reportPeriod 2021-07-310001628280-21-018495
2021-09-1316:17 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001628280-21-018477
2021-08-3017:07 ETDEF 14AProxy statementPeriod 2021-08-300001628280-21-017794
2021-07-2617:23 ET10-KAnnual reportPeriod 2021-04-300001628280-21-014464
2021-07-2208:15 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001628280-21-014235
2021-03-1515:11 ET10-QQuarterly reportPeriod 2021-01-310001628280-21-004710
2021-03-1116:02 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001628280-21-004535
2021-02-1210:57 ET8-K5.02 Departure or appointment of officers or directors0001628280-21-002048
2020-12-1417:19 ET10-QQuarterly reportPeriod 2020-10-310001628280-20-017479
2020-12-1416:00 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001628280-20-017470
2020-10-2115:24 ET8-K5.07 Shareholder vote results0001628280-20-014644
2020-10-1517:09 ET8-K9.01 Financial statements and exhibits0001628280-20-014503
2020-09-1416:45 ET10-QQuarterly reportPeriod 2020-07-310001628280-20-013559
2020-09-1416:00 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001628280-20-013549
2020-08-2816:17 ETDEF 14AProxy statementPeriod 2020-04-300001628280-20-013113
2020-07-2817:29 ET10-KAnnual reportPeriod 2020-04-300001628280-20-010734
2020-07-2716:32 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001628280-20-010661
2020-03-3017:22 ET8-K3.02 Unregistered sale of equity0001628280-20-004386
2020-03-1616:30 ET10-QQuarterly reportPeriod 2020-01-310001628280-20-003637
2020-03-1216:05 ET8-K2.02 Results of operations0001628280-20-003461
2020-01-0315:21 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001628280-20-000084
2019-12-1616:33 ET10-QQuarterly reportPeriod 2019-10-310001628280-19-015106
2019-12-1616:14 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001628280-19-015102
2019-10-1613:27 ET8-K5.07 Shareholder vote results0001628280-19-012310
2019-09-1616:59 ET10-QQuarterly reportPeriod 2019-07-310001628280-19-011753
2019-09-1616:03 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001628280-19-011740
2019-09-0511:28 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001628280-19-011423
2019-08-2816:39 ETDEF 14AProxy statementPeriod 2019-04-300001628280-19-011252
2019-07-2916:25 ET10-KAnnual reportPeriod 2019-04-300001628280-19-009139
2019-07-1516:34 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001628280-19-008752
2019-03-1817:01 ET10-QQuarterly reportPeriod 2019-01-310001628280-19-003086
2019-03-1816:21 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001628280-19-003074
2019-01-0710:12 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001628280-19-000136
2018-12-1716:58 ET10-QQuarterly reportPeriod 2018-10-310001628280-18-015187
2018-12-1716:24 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001628280-18-015177
2018-10-1610:15 ET8-K5.07 Shareholder vote results0001628280-18-012569
2018-09-1416:12 ET10-QQuarterly reportPeriod 2018-07-310001628280-18-011874
2018-09-1316:05 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001628280-18-011830
2018-08-2816:09 ETDEF 14AProxy statementPeriod 2018-04-300001628280-18-011478
2018-07-3017:14 ET10-KAnnual reportPeriod 2018-04-300001628280-18-009773
2018-07-2616:00 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001628280-18-009635
2018-03-1916:30 ET10-QQuarterly reportPeriod 2018-01-310001628280-18-003346

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 10, 2026, 03:33 ET. Listed shows no prices and gives no investment advice.